Repligen and Univercells Technologies have partnered to integrate Repligen’s MAVEN® Real Time Glucose Control Platform with Univercells’ scale-X bioreactors. This collaboration enables real-time monitoring and control of glucose and lactate concentrations during viral vector and vaccine manufacturing, enhancing cell culture process optimization. The MAVEN system provides high-frequency data without media removal, improving nutrient testing automation and data resolution critical for advanced therapy manufacturing.